Massachusetts General Hospital-医療機器分野:企業M&A・提携分析

◆英語タイトル:Massachusetts General Hospital - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8012933
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月27日
◆ページ数:48
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Massachusetts General Hospital (MGH) is a healthcare service provider which offers diagnostic and therapeutic care services. The hospital provides services such as allergy and immunology; ALS multidisciplinary clinic, anesthesia, critical care and pain medicine; back bay healthcare center, beacon hill primary care, blood donor center, Blum center, primary care-revere, burns center, cancer center, cardiac surgery, cardiology and other services. It also provides palliative care, pathology, patient care services, pediatrics and pediatric surgery; pelvic floor disorders center, physical medicine and rehabilitation service; plastic and reconstructive surgery, primary care, primary care associates, psychiatry, pulmonary and critical care medicine, radiation oncology and radiology services, among others. The hospital also provides research, education and training programs. MGH is headquartered in Boston, Massachusetts, the US.

Massachusetts General Hospital – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Massachusetts General Hospital, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Massachusetts General Hospital, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Massachusetts General Hospital, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Massachusetts General Hospital, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Massachusetts General Hospital, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Massachusetts General Hospital, Medical Equipment, Deal Details 12
Partnerships 12
PAVmed Enters into Licensing Agreement with Tufts University, Massachusetts Eye and Ear Infirmary and Massachusetts General Hospital 12
Heidelberg Engineering Enters into Licensing Agreement with Massachusetts General Hospital 14
MolecularMD Enters Into Licensing Agreement For LKB1, Cancer Diagnosis Technology 15
INOVA Diagnostics Enters Into Licensing Agreement With AmberGen And Massachusetts General Hospital For Two Autoantigen Biomarkers 17
Molecular Targeting Technologies Enters Into Licensing Agreement With Massachusetts General Hospital 18
IntegraGen Enters Into Licensing Agreement With Johns Hopkins University And Massachusetts General Hospital 19
LEO Science & Tech Hub Enters into Partnership with MGH Wellman Center for Photomedicine 20
Protea Biosciences Enters into Agreement with Massachusetts General Hospital 21
MyndYou Enters into Research Partnership with Massachusetts General Hospital 22
Infraredx Enters into R&D Agreement with Massachusetts General Hospital 23
EKF Diagnostics Enters into Research Agreement with Massachusetts General Hospital 24
Canon Enters Into Co-Development Agreement With Massachusetts General Hospital And Brigham and Women’s Hospital 25
Perkinelmer Enters Into Co-Development Agreement With Massachusetts General Hospital 26
Affymetrix Enters Into Co-Development Agreement With Massachusetts General Hospital For New Oncology Biomarker Tests 27
Lumenis Enters Into Research, Development And Licensing Agreement With Wellman Center 28
Veridex Enters Into Co-Development Agreement With Massachusetts General Hospital 29
Translational Sciences Enters Into Licensing Agreement with Massachusetts General Hospital & Harvard University 30
Massachusetts General Hospital – Key Competitors 31
Massachusetts General Hospital – Key Employees 32
Massachusetts General Hospital – Locations And Subsidiaries 33
Head Office 33
Other Locations & Subsidiaries 33
Joint Venture 33
Recent Developments 34
Corporate Communications 34
Jan 19, 2016: PENTAX Medical Supports Massachusetts General Hospital with In-Kind Donation to Ugandan Hospital 34
Government and Public Interest 35
Jul 20, 2017: fMRI, EEG may Provide Early Detection of Consciousness in Patients with Severe Traumatic Brain Injury 35
Apr 06, 2017: Urine test may be able to diagnose obstructive sleep apnea in children with Down Syndrome 37
Product News 38
Aug 06, 2017: New AI algorithm Monitors Sleep with Radio Waves 38
Jun 12, 2017: Cardiac CT angiography appears better at predicting future risk for patients with chest pain 40
Apr 12, 2017: WorldCare Clinical Commences Medical Device Study using Advanced Cardiac Imaging 41
Oct 19, 2016: Bracket Announces New Study for Assessment of Brain Insulin Resistance in Alzheimer’s Disease 42
May 06, 2016: Mass. General-developed device may provide rapid diagnosis of bacterial infections 43
Mar 09, 2016: Combining two imaging technologies may better identify dangerous coronary plaques 44
Other Significant Developments 45
Apr 05, 2016: NVIDIA, Massachusetts General Hospital Use Artificial Intelligence to Advance Radiology, Pathology, Genomics 45
Mar 29, 2016: Massachusetts General Hospital embarks on clinical analytical study using Philips’ IntelliSite Solution to advance digital pathology adoption in the United States 46
Feb 23, 2016: Upland Software Helps Healthcare Clients Effectively Plan and Manage Project Workloads 47
Appendix 48
Methodology 48
About GlobalData 48
Contact Us 48
Disclaimer 48

List of Tables
Massachusetts General Hospital, Medical Equipment, Key Facts 2
Massachusetts General Hospital, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Massachusetts General Hospital, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Massachusetts General Hospital, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Massachusetts General Hospital, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Massachusetts General Hospital, Deals By Market, 2011 to YTD 2017 9
Massachusetts General Hospital, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
PAVmed Enters into Licensing Agreement with Tufts University, Massachusetts Eye and Ear Infirmary and Massachusetts General Hospital 12
Heidelberg Engineering Enters into Licensing Agreement with Massachusetts General Hospital 14
MolecularMD Enters Into Licensing Agreement For LKB1, Cancer Diagnosis Technology 15
INOVA Diagnostics Enters Into Licensing Agreement With AmberGen And Massachusetts General Hospital For Two Autoantigen Biomarkers 17
Molecular Targeting Technologies Enters Into Licensing Agreement With Massachusetts General Hospital 18
IntegraGen Enters Into Licensing Agreement With Johns Hopkins University And Massachusetts General Hospital 19
LEO Science & Tech Hub Enters into Partnership with MGH Wellman Center for Photomedicine 20
Protea Biosciences Enters into Agreement with Massachusetts General Hospital 21
MyndYou Enters into Research Partnership with Massachusetts General Hospital 22
Infraredx Enters into R&D Agreement with Massachusetts General Hospital 23
EKF Diagnostics Enters into Research Agreement with Massachusetts General Hospital 24
Canon Enters Into Co-Development Agreement With Massachusetts General Hospital And Brigham and Women’s Hospital 25
Perkinelmer Enters Into Co-Development Agreement With Massachusetts General Hospital 26
Affymetrix Enters Into Co-Development Agreement With Massachusetts General Hospital For New Oncology Biomarker Tests 27
Lumenis Enters Into Research, Development And Licensing Agreement With Wellman Center 28
Veridex Enters Into Co-Development Agreement With Massachusetts General Hospital 29
Translational Sciences Enters Into Licensing Agreement with Massachusetts General Hospital & Harvard University 30
Massachusetts General Hospital, Key Competitors 31
Massachusetts General Hospital, Key Employees 32
Massachusetts General Hospital, Subsidiaries 33
Massachusetts General Hospital, Joint Venture 33

★海外企業調査レポート[Massachusetts General Hospital-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Daicel Corp (4202):企業の財務・戦略的SWOT分析
    Daicel Corp (4202) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Tragara Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Tragara Pharmaceuticals Inc (Tragara Pharmaceuticals) is a pharmaceutical company focused on the clinical and commercial development of its proprietary medicines for the treatment of various cancers. Its lead product candidate TG02, an oral multi-kinase inhibitor facilitates anti-tumor activ …
  • Navidea Biopharmaceuticals Inc (NAVB)-医療機器分野:企業M&A・提携分析
    Summary Navidea Biopharmaceuticals Inc (Navidea) is a precision medicine company that focuses on the development and commercialization of radiopharmaceutical agents and precision diagnostics. Its key product, Lymphoseek (technetium Tc 99m tilmanocept) injection, is a radiopharmaceutical agent used i …
  • Brookdale Senior Living Inc (BKD):製薬・医療:M&Aディール及び事業提携情報
    Summary Brookdale Senior Living Inc (Brookdale) operates senior living communities which provide properties with high quality service, care and living accommodations for residents. The company focuses on providing an independent living, assisted living, dementia care, skilled nursing, continuing car …
  • The Ensign Group Inc (ENSG):企業の財務・戦略的SWOT分析
    The Ensign Group Inc (ENSG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Eidgenossische Technische Hochschule Zurich:製薬・医療:M&Aディール及び事業提携情報
    Summary Eidgenossische Technische Hochschule Zurich (ETH Zurich) is an educational service provider that offers studies in technology and the natural sciences. The university offers scientific education through bachelor programmes and master programmes in the areas of applied geophysics, architectur …
  • ENAMINE Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Enamine Ltd (Enamine) is a provider of screening and drug discovery services. The company’s products include building blocks and intermediates, screening compounds, real database, compound libraries, fragment library, tangible building blocks, materials chemistry and scaffolds. It offers ser …
  • Experian PLC (EXPN):企業の財務・戦略的SWOT分析
    Experian PLC (EXPN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Richoux Group Plc:企業の戦略・SWOT・財務情報
    Richoux Group Plc - Strategy, SWOT and Corporate Finance Report Summary Richoux Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Clearside BioMedical Inc (CLSD):企業の財務・戦略的SWOT分析
    Summary Clearside BioMedical Inc (Clearside) is a clinical biopharmaceutical company that develops treatments for vision impairment associated with uveitic macular edema. The company’s pipeline products comprise Uveitis, macular edema associated with non- infectious uveitis; RVO - Retinal Vein Occlu …
  • Ryosan Company, Ltd:企業の戦略・SWOT・財務分析
    Ryosan Company, Ltd - Strategy, SWOT and Corporate Finance Report Summary Ryosan Company, Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Iconic Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Iconic Therapeutics Inc (Iconic Therapeutics) is a biopharmaceutical company that provides translation of scientific insight into breakthrough medicines. The company offers development of tissue factor in angiogenesis, inflammation, and metastasis that led to develop new approach to retinal …
  • Virometix AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Virometix AG (Virometix) is a biotechnology company that develops vaccines and immunotherapeutic drugs for the prevention and treatment of infectious and chronic human diseases. The company’s pipeline products include prophylactic and therapeutic vaccines for infectious, respiratory, and onc …
  • Systematic A/S:企業の戦略・SWOT・財務分析
    Systematic A/S - Strategy, SWOT and Corporate Finance Report Summary Systematic A/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Seplat Petroleum Development Company Plc (SEPLAT):石油・ガス:M&Aディール及び事業提携情報
    Summary Seplat Petroleum Development Company Plc (Seplat) is an independent upstream exploration and production company that offers development and operation of oil and natural gas reserves and production assets. The company produces oil from fileds such as Amukpe, Oben, Okporhuru, Ovhor, Orogho, Sa …
  • Pacific Edge Ltd (PEB):製品パイプライン分析
    Summary Pacific Edge Ltd (PEB) is a diagnostics company that discovers, develops and commercializes diagnostic tests for the early detection and monitoring of cancer. The company provides lead product such as Cxbladder, a non-invasive laboratory test for the detection of bladder cancer. It is develo …
  • CareDx Inc (CDNA):企業の製品パイプライン分析
    Summary CareDx Inc (CareDx) formerly XDx Inc, is a molecular diagnostics company focused on the discovery, development, and commercialization of diagnostic solutions for transplant patients. The company offers products which include AlloMap, a noninvasive blood test used by clinicians to monitor and …
  • Statnett SF-エネルギー分野:企業M&A・提携分析
    Summary Statnett SF (Statnett) transmits and distributes high voltage electricity in Norway primarily generated from its hydro-electric power plants. It operates as a system operator in the Norwegian energy system. The company is a state enterprise, established under the Act relating to state-owned …
  • The Broad Institute Inc-医療機器分野:企業M&A・提携分析
    Summary The Broad Institute Inc (Broad Institute), a subsidiary of The Broad Foundation is a non-profit research organization that conducts genomic research for treatment of human diseases. The organization transforms medicine by utilizing systematic approaches in biological sciences, to speed up th …
  • Maistra d.d.:企業の戦略・SWOT・財務情報
    Maistra d.d. - Strategy, SWOT and Corporate Finance Report Summary Maistra d.d. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆